Invion Limited

IVIXFOTCHealthcare● Active

$0.00

$-0.04(-95.12%)

Market Cap$174538

P/E Ratio—

52W High$0.0369

52W Low$0.0018

Avg Volume1.168

Open$0.04

Beta0.44

Free Cash Flow Financials Revenue

Invion Limited (IVIXF) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

IVIXF · free cash flow · updated Jun 9, 2026

Core FCF metrics

IVIXF · FCF · TTM · margin & CAGR

Free cash flow was −$2.0M for FY2025 (fiscal year ending 2025-06-30), up 21.9% year-over-year

FY2025 Free Cash Flow−$2.0M▲ +21.9% YoY

Trailing 12M (TTM)−$3.2Mtrailing 4 quarters sum

FCF Margin——

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

IVIXF · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$2.0M(0M)−$2.0M▲ +21.9%—

FY2024−$1.6M(1M)−$2.5M▲ +14.4%-101.5%

FY2023−$1.2M(2M)−$2.9M▲ +49.3%-106.9%

FY2022−$765,163(5M)−$5.8M▼ 1938.1%-253.9%

FY2021$313,795(0M)$313,795▲ +398.9%17.9%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

IVIXF · P/FCF · FCF yield · FCF per share

Invion Limited (IVIXF) reported negative free cash flow of −$0.00B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

IVIXF · cash flow statement · operating / investing / financing

For FY2025, Invion Limited generated −$2.0M in operating cash flow and spent 0M in capital expenditures, yielding −$2.0M in free cash flow.

Operating Activities

−$2.0M

Cash from core business operations

2025-06-30

Investing Activities

+$0.0M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

+$2.0M

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF (−$2.0M) − |CapEx| (0M) = FCF (−$2.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

IVIXF vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Invion LimitedYOU

IVIXF

−$2.0M+21.9%—

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Invion Limited (IVIXF) reported free cash flow of −$2.0M for FY2025 (fiscal year ending 2025-06-30), up 21.9% year-over-year.

Based on available data, Invion Limited has maintained positive free cash flow for at least 2 fiscal year(s). FCF peaked at $522,433 in FY2018.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

IVIXF free cash flow · 8 questions

Invion Limited free cash flow was −$2.0M for FY2025, up 21.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$3.2M.

IVIXF free cash flowIVIXF FCFIVIXF FCF 2025IVIXF free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Invion Limited · Invion Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026